# Cradle Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cradle-bio-b-v

- Industry: Biotechnology
- Headquarters: Delft, Netherlands
- Website: www.cradle.bio
- Total disclosed funding: $103M
- Latest round: Series B (Nov 14, 2024)
- Investors on record: 3

## About

Founded in 2021 and based in Amsterdam, Netherlands, Cradle Bio B.V., also known as Cradle, operates as a biotechnology company that develops algorithms and artificial intelligence-assisted tools to design cells and proteins that can produce fabrics, food, fuel, and medicines for biologists. In November 2023, Cradle Bio B.V. raised EUR 22 million in Series A funding led by Index Ventures, Kindred Capital.

The company operates as a developer of AI-powered design tools that enable proteins's 3D modeling and automated sequence generation. The tool is also equipped with optimized thermostability and codon optimization.

The company plans to use the funds raised in November 2023 to support growth by increasing production capacity and sales activity and expanding the market reach of its platform.

## Funding rounds

- Series B, Nov 14, 2024, $73M — Index Ventures, Institutional Venture Partners, Kindred Capital
- Series A, Nov 28, 2023, $24M — Index Ventures, Kindred Capital
- Seed, Nov 17, 2022, $5.7M — Index Ventures, Kindred Capital

## Investors

- Index Ventures (https://capitalatlas.ai/funds/index-ventures) — Seed, Series A, Series B
- Kindred Capital (https://capitalatlas.ai/funds/kindred-capital) — Seed, Series A, Series B
- Institutional Venture Partners (https://capitalatlas.ai/funds/institutional-venture-partners) — Series B